wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

QA QC cGMP

Total questions: 30

Worksheet time: 15mins

Name
Class
Date
1.

Quality Control is a ____ tool

a)

Preventive

b)

Corrective

c)

Managerial

d)

Distribution

2.

_____ regulations must be followed by drug manufacturing companies

a)

GMP

b)

cGMP

c)

GWP

d)

GGP

3.

_____ is a set of principles intended to assure the quality and integrity of non-clinical laboratory studies

a)

GMP

b)

GLP

c)

GCP

d)

GDP

4.

____ regulates drug products defined in FDA

a)

CSER

b)

CDER

c)

CEFB

d)

CBRE

5.

Storage, retention and retrieval of documents is a responsibility of ____

a)

R&D Dept

b)

QC Dept

c)

QA Dept

d)

Stores Dept

6.

Packaging and Labeling control is a part of ____

a)

GLP

b)

GMP

c)

GDP

d)

GCP

7.

____ ensures consistency in daily operations

a)

SOPs

b)

Quality assurance

c)

Quality Control measures

d)

Material analysis

8.

CDER stands for _____

a)

Center for Drug Research and Evaluation

b)

Center for Drug and Research

c)

Center for Drug Evaluation and Research

d)

Center for Drug Evaluation and Review

9.

CBER stands for ______

a)

Center for Biological Evaluation

b)

Central Biological Evaluation and Research

c)

Center for Biologics Evaluation and Review

d)

Center for Biologics Evaluation and Research

10.

EMEA stands for ____

a)

European Medical Evaluation Agent

b)

European Medicines Evaluation Agency

c)

European Medicines Enterprise Agency

d)

Europe Medicine Entry Agency

11.

GMP applies to _____

a)

API

b)

Finished Goods

c)

Both API and finished goods

d)

None of the above

12.

Which of the following are a part of building and facilities?

a)

Storage area

b)

Production area

c)

Weighing area

d)

All of the above

13.

Any product that has completed all processing stages up to, but not including, final packaging is called ____

a)

Bulk product

b)

Final product

c)

Packaged product

d)

None

14.

A dosage form that has undergone all stages of manufacture, including packaging in its final container and labelling is called ____

a)

Bulk product

b)

Finished product

c)

API

d)

None

15.

GCP stands for ___

a)

Good cleaning practices

b)

Good clinical practices

c)

Good carrying practices

d)

Good cleaning and dispensing practices

16.

GMP covers_____

a)

personnel

b)

building premises

c)

sanitation and hygiene

d)

All of the above

17.

Rest and refreshment rooms are part of ___

a)

Storage area

b)

Dispensing area

c)

Ancillary area

d)

None of the above

18.

GWP includes_____

a)

Purchase of pharmaceutical products.

b)

Storage of ordered products

c)

Distribution of stocked products

d)

All of the above

19.

REJECTED MATERIALS area includes____

a)

Receiving area

b)

Sampling area

c)

Dispensed products

d)

Destroyed or unsuitable materials

20.

____ is a part of the Drugs and Cosmetics Act of 1945 that outlines the Good Manufacturing Practices (GMP) for pharmaceutical products in India

a)

Schedule O

b)

Schedule P

c)

Schedule N

d)

Schedule M

21.

According to Schedule M, which of the following is a primary responsibility of production personnel?

a)

To approve batch release

b)

To ensure products are manufactured and stored as per documented procedures

c)

To conduct internal audits

d)

To approve vendor qualification documents

22.

Under USFDA (CDER/CBER) guidelines, training of personnel must be:

a)

Conducted only once during induction

b)

Documented and evaluated periodically for effectiveness

c)

Optional for senior management

d)

Performed only by external consultants

23.

WHO cGMP requires personnel hygiene programs to include all except

a)

Use of protective garments

b)

Periodic health checks

c)

Mandatory annual leave

d)

Training in personal hygiene practices

24.

As per Schedule M, the location of a drug manufacturing unit should ideally

a)

Be close to densely populated residential areas

b)

Be situated in an industrial area with minimal environmental contamination

c)

Be near agricultural land for easy waste disposal

d)

Have no restrictions on surrounding activities

25.

EU (EMA) GMP guidelines emphasize that the plant layout must:

a)

Encourage unidirectional flow of materials and personnel

b)

Allow free and random movement of personnel

c)

Support common change rooms for sterile and non-sterile operations

d)

Have no segregation for high-risk areas

26.

During a USFDA inspection, investigators find that three operators involved in aseptic filtration lack documented training for a newly introduced sterile filter integrity test.

Which is the MOST appropriate regulatory observation?

a)

Inadequate maintenance of QMS audits

b)

Failure to qualify personnel as per 21 CFR 211.25

c)

Failure to validate utilities as per EMA Annex 1

d)

Poor plant layout design per Schedule M

27.

A purified water loop repeatedly exceeds microbial limits. Investigators find that sanitization frequency was increased informally without updating SOPs.

What is the KEY compliance failure?

a)

Not performing change control as per PIC/S

b)

Not monitoring temperature continuously

c)

Incorrect HVAC classification

d)

Inadequate operator hygiene program

28.

A facility’s compressed air used for product contact intermittently fails dew-point specifications, but engineering logs only note “machine serviced—OK.”

Which regulatory issue is most significant?

a)

Lack of documented preventive maintenance as per Schedule M

b)

Improper HVAC zoning

c)

MA requirement on computerized system validation

d)

WHO requirement for handwashing facilities

29.

During a Schedule M audit, the inspector reviews personnel files and finds no written job descriptions for key roles such as production chemist, QA reviewer, and engineering supervisor.

What is the most significant cGMP risk?

a)

Inability to calculate manpower cost accurately

b)

Ambiguity in responsibilities leading to accountability failures

c)

Inconsistent cleaning of AHUs

d)

Reduced efficiency in water system sanitization

30.

PIC (or PIC/S) stands for:

a)

Pharmaceutical Inspection Convention / Scheme

b)

Pharmaceutical Industry Council / Scheme

c)

Public Inspection Committee

d)

Pharma Investigation Council